BCA
PMD

Bray Capital Advisors’s Psychemedics Corporation PMD Stock Holding History

Bray Capital Advisors’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-206
Closed -$2K – 322
2019
Q3 		$2K Buy
+206
New +$1.75K ﹤0.01% 334

Other funds holding PMD

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
CIC
Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Bray Capital Advisors's PMD Position: Q4 2019 in Review

Bray Capital Advisors sold out of Psychemedics Corporation (PMD) in Q4 2019, closing a stake of 206 shares — an estimated $2K sold.

Bray Capital Advisors first reported a position in PMD in Q3 2019 and held it in 1 quarter. The position peaked at $2K in Q3 2019. 42 funds tracked by Wall St. Rank hold PMD as of Q4 2019.

  • Bray Capital Advisors reported no remaining Psychemedics Corporation position as of Q4 2019 after selling out during the quarter.
  • Bray Capital Advisors sold 206 Psychemedics Corporation shares in Q4 2019, an estimated $2K.
  • Bray Capital Advisors first reported a position in Psychemedics Corporation in Q3 2019 and held it in 1 quarter.
  • Bray Capital Advisors's Psychemedics Corporation position peaked at $2K in Q3 2019.
  • 42 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q4 2019.

Based on Bray Capital Advisors's 13F filing for Q4 2019, filed 31 Jan 2020.